Gewinn- und Verlustrechnung von Eli Lilly

gurufocus.com2026-08-21 15:03:00

Eli Lilly Jumps as Weight-Loss Leadership Drives Another Breakout

Eli Lilly (LLY), the drugmaking giant behind Mounjaro and Zepbound, jumped approximately 1.9% to $1,268.23 Friday afternoon. Thursday's dip did not scare buyers

fool.com2026-08-20 17:14:01

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.

247wallst.com2026-08-19 12:00:24

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?

Among the pharma names investors debate most, Eli Lilly (NYSE:LLY | LLY Price Prediction) at $1,216.46 screens most constructively, Novo Nordisk (NYSE:NVO) at $45.92 looks range-bound, and Merck (NYSE:MRK) at $135.97 screens as fairly valued.

zacks.com2026-08-19 10:46:13

Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

247wallst.com2026-08-19 09:30:59

Stock Forecast: The Market is Sleeping on Eli Lilly's Next $1 Trillion Opportunity

Eli Lilly (NYSE:LLY | LLY Price Prediction) has quietly transformed itself into the first pharmaceutical company ever valued above $1 trillion, and yet the market may still be underpricing what comes next.

investors.com2026-08-19 08:00:19

Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market

The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs.

benzinga.com2026-08-19 07:46:02

Netflix, Eli Lilly, Elanco Animal Health And More Stock On CNBC's ‘Final Trades'

On CNBC's “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, recommended Netflix, Inc. (NASDAQ:NFLX).